ENTA

ENANTA PHARMACEUTICALS INC

Healthcare

Biotechnology

Mkt cap: $385.7M

ENANTA PHARMACEUTICALS INC is a Healthcare company operating in Biotechnology with a $385.7M market cap.

ENTA beat consensus EPS by 0.4% in Q1 FY2026, reported May 10, 2026.

14 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

IR URL not yet extracted for ENTA.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 14 calls

History

Earnings history

20 quarters

Q1 FY20262026-05-10
EPS$-0.45 vs $-0.78
+42.5%
Rev$17.2M vs —
—
EODHD
Q4 FY20252026-02-08
EPS$-0.42 vs $-0.81
+48.1%
Rev$18.6M vs —
—
EODHD
Q3 FY20252025-11-30
EPS$-0.87

Track Record

Sample

Spoken Alpha tracks ENTA's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.

Beat rate

5/10

50%

Positive 1D reaction

4/10

40%

Avg 1D reaction

-2.3%

vs sector median

-2.1%

Healthcare

Beats consensus 5/10 quarters with 40% positive reaction rate

Sample

Top executives

Sample

Spoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ENTA.

$ curl https://api.spokenalpha.com/v1/companies/ENTA

Get an API key API docs

FAQ

Frequently asked about ENTA

Where can I find ENANTA PHARMACEUTICALS INC's (ENTA) earnings call transcripts?

Spoken Alpha indexes ENTA's earnings call transcripts at https://spokenalpha.com/companies/ENTA. Each call links to attributed speakers and parsed analyst Q&A.

When was ENANTA PHARMACEUTICALS INC's most recent earnings call?

ENANTA PHARMACEUTICALS INC (ENTA) held its most recent earnings call on 2024-05-06, covering fiscal Q2 2024.

What sector is ENTA in?

ENANTA PHARMACEUTICALS INC (ENTA) operates in the Healthcare sector (Biotechnology industry).

Q4 FY2023

Earnings

2023-11-2018 Q&A exchanges

Q2 FY20252025-08-10

EPS$-0.85 vs $-0.88

+3.4%

Rev$18.3M vs —

—

EODHD

Q1 FY20252025-05-11

EPS$-1.06 vs $-1.14

+7.0%

Rev$14.9M vs —

—

EODHD

Q4 FY20242025-02-09

EPS$-1.05 vs $-1.35

+22.2%

Rev$17.0M vs —

—

EODHD

Q3 FY20242024-11-24

EPS$-1.36 vs $-0.92

-47.8%

Rev$14.6M vs —

—

EODHD

Q2 FY20242024-08-04

EPS$-1.07 vs $-1.45

+26.2%

Rev$18.0M vs —

—

EODHD

Q1 FY20242024-05-05

EPS$-1.47 vs $-1.33

-10.5%

Rev$17.1M vs —

—

EODHD

Q4 FY20232024-01-25

EPS$-1.58 vs $-1.19

-32.8%

Rev$18.0M vs —

—

EODHD

Q3 FY20232023-11-19

EPS$-1.33 vs $-2.15

+38.1%

Rev$18.9M vs —

—

EODHD

Q2 FY20232023-08-06

EPS$-1.86 vs $-2.34

+20.5%

Rev$18.9M vs —

—

EODHD

Q1 FY20232023-05-07

EPS$-1.79 vs $-1.98

+9.6%

Rev$17.8M vs —

—

EODHD

Q4 FY20222023-02-06

EPS$-1.39 vs $-1.59

+12.6%

Rev$23.6M vs —

—

EODHD

Q3 FY20222022-11-20

EPS$-1.27 vs $-1.35

+5.9%

Rev$20.3M vs —

—

EODHD

Q2 FY20222022-08-07

EPS$-1.53 vs $-1.39

-10.1%

Rev$19.5M vs —

—

EODHD

Q1 FY20222022-05-08

EPS$-1.63 vs $-1.43

-14.0%

Rev$18.7M vs —

—

EODHD

Q4 FY20212022-02-07

EPS$-1.48 vs $-1.08

-37.0%

Rev$27.6M vs —

—

EODHD

Q3 FY20212021-11-21

EPS$-1.22 vs $-1.22

0.0%

Rev$23.6M vs —

—

EODHD

Q2 FY20212021-08-04

EPS$-1.19 vs $-1.28

+7.0%

Rev$21.6M vs —

—

EODHD

Period	Reported	EPS actual	EPS consensus	EPS surprise	Revenue actual	Revenue consensus	Rev. surprise	Source
Q1 FY2026	2026-05-10	$-0.45	$-0.78	+42.5%	$17.2M	—	—	EODHD
Q4 FY2025	2026-02-08	$-0.42	$-0.81	+48.1%	$18.6M	—	—	EODHD
Q3 FY2025	2025-11-30	$-0.87	$-1.01	+13.9%	$15.1M	—	—	EODHD
Q2 FY2025	2025-08-10	$-0.85	$-0.88	+3.4%	$18.3M	—	—	EODHD
Q1 FY2025	2025-05-11	$-1.06	$-1.14	+7.0%	$14.9M	—	—	EODHD
Q4 FY2024	2025-02-09	$-1.05	$-1.35	+22.2%	$17.0M	—	—	EODHD
Q3 FY2024	2024-11-24	$-1.36	$-0.92	-47.8%	$14.6M	—	—	EODHD
Q2 FY2024	2024-08-04	$-1.07	$-1.45	+26.2%	$18.0M	—	—	EODHD
Q1 FY2024	2024-05-05	$-1.47	$-1.33	-10.5%	$17.1M	—	—	EODHD
Q4 FY2023	2024-01-25	$-1.58	$-1.19	-32.8%	$18.0M	—	—	EODHD
Q3 FY2023	2023-11-19	$-1.33	$-2.15	+38.1%	$18.9M	—	—	EODHD
Q2 FY2023	2023-08-06	$-1.86	$-2.34	+20.5%	$18.9M	—	—	EODHD
Q1 FY2023	2023-05-07	$-1.79	$-1.98	+9.6%	$17.8M	—	—	EODHD
Q4 FY2022	2023-02-06	$-1.39	$-1.59	+12.6%	$23.6M	—	—	EODHD
Q3 FY2022	2022-11-20	$-1.27	$-1.35	+5.9%	$20.3M	—	—	EODHD
Q2 FY2022	2022-08-07	$-1.53	$-1.39	-10.1%	$19.5M	—	—	EODHD
Q1 FY2022	2022-05-08	$-1.63	$-1.43	-14.0%	$18.7M	—	—	EODHD
Q4 FY2021	2022-02-07	$-1.48	$-1.08	-37.0%	$27.6M	—	—	EODHD
Q3 FY2021	2021-11-21	$-1.22	$-1.22	0.0%	$23.6M	—	—	EODHD
Q2 FY2021	2021-08-04	$-1.19	$-1.28	+7.0%	$21.6M	—	—	EODHD

Source: EODHD. ENTA reported actuals as published; sparse fields render as —.

Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.

Missed in 2 of the last 4 quarters

Sample

Recent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.

Quarterly beats & misses

Sample

Q1 FY2024

$1.19 vs $1.19

+0.4%

1D -2.1%

Q4 FY2024

$1.18 vs $1.38

-14.5%

1D -1.3%

Q3 FY2024

$1.23 vs $1.26

-2.5%

1D -5.9%

Q2 FY2024

$1.22 vs $1.22

-0.2%

1D -8.9%

Q1 FY2023

$1.25 vs $1.27

-1.3%

1D +0.9%

Q4 FY2023

$1.35 vs $1.37

-1.4%

1D -6.2%

Q3 FY2023

$1.43 vs $1.42

+0.4%

1D +1.2%

Q2 FY2023

$1.45 vs $1.44

+0.8%

1D -3.9%

Q1 FY2022

$1.29 vs $1.29

-0.3%

1D +0.6%

Q4 FY2022

$1.21 vs $1.41

-14.3%

1D +2.7%

Quarter	Actual EPS	Consensus	Surprise	1D	5D
Q1 FY2024	$1.19	$1.19	+0.4%	-2.1%	-0.3%
Q4 FY2024	$1.18	$1.38	-14.5%	-1.3%	+0.8%
Q3 FY2024	$1.23	$1.26	-2.5%	-5.9%	-6.5%
Q2 FY2024	$1.22	$1.22	-0.2%	-8.9%	-9.9%
Q1 FY2023	$1.25	$1.27	-1.3%	+0.9%	+3.5%

Guidance change history

Sample

Q1 FY2024
Maintained
2024-04-15
Q4 FY2024
Lowered
2024-13-15
Q3 FY2024
Maintained
2024-10-15
Q2 FY2024
Maintained
2024-07-15
Q1 FY2023
Maintained
2023-04-15
Q4 FY2023
Suspended
2023-13-15
Q3 FY2023
Maintained
2023-10-15
Q2 FY2023
Suspended
2023-07-15

OTHER_C_SUITE since 2025 • 1/2 beats (50%) • guidance suspended Q3 FY2024

BullFrog AI Holdings, Inc.

Overview

Management language signature

Investor Relations

Recent earnings calls

Earnings history

Track Record

Top executives

Other companies in Healthcare

For developers and AI agents

Frequently asked about ENTA

Quarterly beats & misses

Guidance change history